Biologically Active Small Molecules, 1097917-15-1

Compare Tool

Select up to 3 products

HomeAll Products

1097917-15-1 Biologically Active Small Molecules

1 - 2 of 2
Sort
View
Show
  • LKT Labs

    ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models.

  • Cayman Chemical

    An ATP-competitive, second-generation ALK inhibitor (IC50 = 3.5 nM) that also inhibits ROS (IC50 = 8.9 nM) and ACK (IC50 = 5.8 nM); demonstrates antitumor activity in xenograft mouse models and has been shown to overcome crizotinib resistance in non-small cell lung cancer.

Compare Tool

Select up to 3 products